Navamedic Asa Stock Current Liabilities
| NAVA Stock | NOK 25.00 0.70 2.72% |
Navamedic ASA fundamentals help investors to digest information that contributes to Navamedic ASA's financial success or failures. It also enables traders to predict the movement of Navamedic Stock. The fundamental analysis module provides a way to measure Navamedic ASA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Navamedic ASA stock.
Navamedic |
Navamedic ASA Company Current Liabilities Analysis
Navamedic ASA's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current Navamedic ASA Current Liabilities | 116 M |
Most of Navamedic ASA's fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Navamedic ASA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
In accordance with the recently published financial statements, Navamedic ASA has a Current Liabilities of 116 M. This is 93.38% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The current liabilities for all Norway stocks is 98.53% higher than that of the company.
Navamedic Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Navamedic ASA's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Navamedic ASA could also be used in its relative valuation, which is a method of valuing Navamedic ASA by comparing valuation metrics of similar companies.Navamedic ASA is currently under evaluation in current liabilities category among its peers.
Navamedic Fundamentals
| Return On Equity | 0.073 | |||
| Return On Asset | 0.0633 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.1 % | |||
| Current Valuation | 578.31 M | |||
| Shares Outstanding | 16.35 M | |||
| Shares Owned By Insiders | 41.56 % | |||
| Shares Owned By Institutions | 14.08 % | |||
| Price To Earning | 9.39 X | |||
| Price To Book | 3.04 X | |||
| Price To Sales | 1.57 X | |||
| Revenue | 278.44 M | |||
| Gross Profit | 111.74 M | |||
| EBITDA | 11.57 M | |||
| Net Income | 2.36 M | |||
| Cash And Equivalents | 52.62 M | |||
| Cash Per Share | 1.28 X | |||
| Total Debt | 44.8 M | |||
| Debt To Equity | 0.14 % | |||
| Current Ratio | 1.17 X | |||
| Book Value Per Share | 9.25 X | |||
| Cash Flow From Operations | (1.3 M) | |||
| Earnings Per Share | 0.46 X | |||
| Target Price | 46.0 | |||
| Number Of Employees | 28 | |||
| Beta | 0.47 | |||
| Market Capitalization | 539.41 M | |||
| Total Asset | 330.18 M | |||
| Retained Earnings | (62 M) | |||
| Working Capital | 15 M | |||
| Current Asset | 131 M | |||
| Current Liabilities | 116 M | |||
| Z Score | 7.2 | |||
| Net Asset | 330.18 M |
About Navamedic ASA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Navamedic ASA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Navamedic ASA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Navamedic ASA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Navamedic Stock
Navamedic ASA financial ratios help investors to determine whether Navamedic Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Navamedic with respect to the benefits of owning Navamedic ASA security.